Novavax Seeks Emergency Use Authorization for Covid Vaccine in South Africa
Novavax Inc. (NASDAQ: NVAX), along with Serum Institute of India (SII), announced a regulatory submission to the South African Health Products Regulatory Agency (SAHPRA) for emergency use authorization (EUA) of its Covid-19 vaccine. If approved, the vaccine is set to be manufactured and commercialized by SII South Africa under the name Covavax. [stock_market_widget type=”inline-label” template=”basic9″ …
Novavax Seeks Emergency Use Authorization for Covid Vaccine in South Africa Read More »